Department updates

» Go to news main

Dr. Abdolell's firm's software gets regulatory nods

Posted by THE CHRONICLE HERALD on December 3, 2015 in Breast, News
Dr. Mo Abdolell
Dr. Mo Abdolell

Photo: Tim Krochak

From the Herald Business:

Dr. Abdolell got the green light from regulators in Europe and Canada for software it developed to improve screening for breast cancer.

Densitas Inc. says it has received both a medical device licence from Health Canada and the CE mark from the European Commission for its flagship product, DM-Density.

“It’s exciting to have DM-Density entering markets with such great potential for sales,” Mohamed Abdolell, the firm’s CEO and a professor at Dalhousie University, said in a news release.

“Our products will address the real clinical challenges in the mammography enterprise, focusing on key value pathways that lead to improved care for women.”

The company’s first commercial software technology, DM-Density provides precise and consistent breast density measurements from digital images taken during mammograms.

Founded in 2011, the firm earned International Organization for Standardization certification earlier this year and is working on regulatory clearances for the product in the United States.

Company representatives are in Chicago this week for the Radiological Society of North America’s annual meeting and presented the technology earlier this year at the European Congress of Radiology in Vienna.

The European appearance generated interest, and company spokeswoman Adele MacLean told The Chronicle Herald in October the firm hoped the U.S. conference would produce a similar response.


All comments require a name and email address. You may also choose to log-in using your preferred social network or register with Disqus, the software we use for our commenting system. Join the conversation, but keep it clean, stay on the topic and be brief. Read comments policy.

comments powered by Disqus